Efficacy and safety of Changfu peritoneal dialysis solution:a multi-center prospective randomized co

来源 :中华医学杂志(英文版) | 被引量 : 0次 | 上传用户:bupingzhenren
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Background A multi-center large scale study is needed to confirm the efficacy and safety of domestic peritoneal dialysis (PD) solutions.Some researchers believe that 6 L/d is enough for adequate dialysis,but there is no multi-center prospective study on Chinese population to confirm this.In this study,we evaluated the efficacy and safety of domestic PD solution (Changfu) and its difference between 6 L and 8 L dosage.Methods Adult PD patients who had taken PD therapy for at least one month were selected and divided into four groups according to two dialysis solution brands and two dialysis dosages,i.e.,6 L dose with Changfu dialysis solution,6 L dose with Baxter dialysis solution,8 L dose with Changfu dialysis solution,and 8 L dose with Baxter dialysis solution.After 48 weeks,the changes of primary and secondary efficacy indices were compared between different types and different dosages.We also analyzed the changes of safety indices.Results Changes of KW from baseline to 48 weeks between Changfu and Baxter showed no statistical differences; so did those of creatinine clearance rate (Ccr).Normalized protein catabolic rate (nPCR) from baseline to 48 weeks between Changfu and Baxter showed no statistical differences; so did those of net ultrafiltration volume (nUF) and estimated glomerular filtration rate (eGFR).Changes of nPCR from baseline to 48 weeks between 6 L and 8 L showed no statistical differences; so did those of nUF and eGFR.The decline of KW from baseline to 48 weeks in 6 L group was more than that in 8 L group.Change of Ccr was similar.During the 48-week period,the mean Kt/V was above 1.7/w,and mean Ccr was above 50 L·1.73 m-2·w-1.More adverse events were found in Changfu group before Changfu Corporation commenced technology optimization,and the statistical differences disappeared after that.Conclusions The domestic PD solution (Changfu) was proven to be as effective as Baxter dialysis solution.During 48-week period,a dosage of 6 L/d was enough for these patients to reach adequate PD.Clinical study promotes technological optimization,further helps to improve the safety indices of the medical products.
其他文献
《中华耳鼻咽喉科杂志》作为中华医学会主办的耳鼻咽喉科学专业学术期刊,承载着全国耳鼻咽喉科界同行的智慧和期望,凝聚了几代人的心血与辛劳,已走过了半个多世纪的历程.50多年来,随着耳鼻咽喉专业在广度和深度上的进展,本刊紧跟国际潮流,及时反映我国耳鼻咽喉发展的最新成就,引导专业水平不断走向新的高度.近20年来,不少前贤为学科外延和内涵的发展,为专科学会和杂志的正名以促进发展,做出了不懈努力.在新世纪的第
目的比较胸腰椎陈旧性骨折继发后凸畸形患者与正常成人的Roussouly分型情况,评价胸腰椎陈旧性骨折继发不同后凸畸形角度对脊柱矢状位生理曲度的影响,进而为临床明确胸腰椎陈旧性骨折继发后凸畸形患者病情和治疗方案提供理论依据。方法采用回顾性病例对照研究分析2014年1月— 2015年12月因胸腰椎陈旧性骨折继发不同程度后凸畸形患者49例(骨折组)。损伤部位:T11 4例,T12 14例,L1 25例,
介绍了填石路提施工质量控制方法.
Background Many recipients of implantable cardiac electronic devices have atrial fibrillation (AF) occurrences after device implantation,even if there is no pre
辗转世界求学,精益求精做手术rn师从国际脊柱侧弯协会原主席、脊柱侧弯Lenke分型提出者Lenke教授,以及原主席Kenneth教授专业学习脊柱侧弯诊治.从事脊柱外科的基础与临床近20
期刊
皮肤黏膜淋巴结综合征(称MCLS),是一种全身性血管炎,主要在婴儿和儿童发病^[1]。我院2001年2月至2008年7月共收治了11例皮肤黏膜淋巴结综合征患儿,现将对其的临床观察和护理总结报
中耳炎是一个古老的课题,早在耳鼻咽喉科尚未分化为一个独立的学科之前,其治疗就开始了,然而迄今发病率依然很高.随着现代医学和科学技术的发展,对它的认识和治疗有了很大进展.中耳炎是一个常见病和多发病,严重影响着人类的健康和生活质量.因此我国耳鼻咽喉科学工作者迫切感到有必要坐到一起,对中耳炎的分类分型和手术治疗的分类进行讨论,以更好地指导临床实践.
期刊
2018年11月23日,由《中华创伤骨科杂志》编辑部主办的“第四届中华创伤骨科杂志脊柱脊髓损伤病例大赛总决赛”于厦门国际会议中心盛大举办.rn总决赛开幕式由本刊编辑部主任、
期刊
Background Cardiac resynchronization therapy (CRT) with biventricular pacing has demonstrated cardiac function improvement for treating congestive heart failure